These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 8681360

  • 1. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J, Skrha J, Perusicová J, Maslowská H, Pochopová L.
    Cas Lek Cesk; 1996 Mar 20; 135(6):174-7. PubMed ID: 8681360
    [Abstract] [Full Text] [Related]

  • 2. [Changes in hemostasis and fibrinolysis in gestational diabetes].
    Kvasnicka J, Bendl J, Zivný J, Umlaufová A, Maslowská H.
    Cas Lek Cesk; 1996 Feb 14; 135(4):106-10. PubMed ID: 8625379
    [Abstract] [Full Text] [Related]

  • 3. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May 14; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

  • 4. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 May 14; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 May 14; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 6. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A, Rosc D, Bronisz M, Szymanski W, Junik R.
    Med Sci Monit; 2008 Nov 14; 14(11):CR574-9. PubMed ID: 18971874
    [Abstract] [Full Text] [Related]

  • 7. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M.
    Pol Merkur Lekarski; 2001 Nov 14; 11(65):414-7. PubMed ID: 11852811
    [Abstract] [Full Text] [Related]

  • 8. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
    Hu XY, Ma YH, Wang C, Yang YH.
    Chin Med J (Engl); 2009 Oct 05; 122(19):2380-5. PubMed ID: 20079143
    [Abstract] [Full Text] [Related]

  • 9. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 Oct 05; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Oct 05; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 11. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr 05; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 12. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P, Kotuličová D, Staško J, Kubisz P.
    Blood Coagul Fibrinolysis; 2011 Sep 05; 22(6):493-8. PubMed ID: 21519232
    [Abstract] [Full Text] [Related]

  • 13. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K, Vít L, Opatrná S, Sulková S, Bodláková B.
    Cas Lek Cesk; 1994 May 30; 133(11):346-9. PubMed ID: 8004664
    [Abstract] [Full Text] [Related]

  • 14. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA.
    J Surg Res; 1998 Jan 30; 74(1):96-101. PubMed ID: 9536981
    [Abstract] [Full Text] [Related]

  • 15. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM, Barrow BA, Grant PJ, Levy JC.
    Diabetologia; 2002 May 30; 45(5):635-41. PubMed ID: 12107743
    [Abstract] [Full Text] [Related]

  • 16. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW, Catto AJ, Carter AM, Grant PJ.
    Diabet Med; 1998 Nov 01; 15(11):953-7. PubMed ID: 9827850
    [Abstract] [Full Text] [Related]

  • 18. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
    Urano T, Sumiyoshi K, Pietraszek MH, Takada Y, Takada A.
    Thromb Haemost; 1991 Oct 01; 66(4):474-8. PubMed ID: 1796399
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 01; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 20. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan 01; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.